Cabaletta Bio ($CABA)

Description

Develops engineered T cell therapies for autoimmune diseases, including rese-cel in Phase 1/2 trials for lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris.

Related

• Kyverna Therapeutics ($KYTX)Develops CAR T-cell therapies for autoimmune diseases, with clinical trials addressing conditions including stiff person syndrome and…
• Kyverna Therapeutics (San Diego)Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing…
• Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
• Century TherapeuticsDevelops off-the-shelf cell therapy candidates from induced pluripotent stem cells for patients with autoimmune conditions, including type…
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
• Artiva Biotherapeutics ($ARTV)Develops off-the-shelf, non-genetically modified natural killer cell therapies for deep B-cell depletion, aiming to help patients with…
• Leibniz-Institut für Immuntherapie (LIT)The institute develops immune cell therapies for cancer, autoimmune disease, and chronic inflammation, spanning discovery research,…
• Bentley Systems ($BSY)Provides infrastructure engineering software for professionals designing, building, and operating infrastructure across sectors and…
• Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial…
• ONK TherapeuticsONK Therapeutics develops ready-made natural killer cell therapies.
• Iovance Biotherapeutics ($IOVA)Develops and manufactures tumor infiltrating lymphocyte therapies that use a patient’s immune cells, serving people with cancer and…
• SNIPR Biome ApSDevelops CRISPR-powered therapies using bacteriophages and engineered probiotics to target antibiotic-resistant bacteria, for academic and…